DOMOMEDIUM SIGNALFINANCIAL10-K

DOMO substantially reduced operating losses while pivoting its strategic messaging toward AI and data products capabilities.

The company's improved profitability trajectory, with operating losses narrowing meaningfully alongside reduced R&D spending, suggests management is balancing growth investments with path-to-profitability objectives. The strategic pivot toward emphasizing AI capabilities and data products positions DOMO to capitalize on current market trends, though execution will be critical.

Comparing 2026-04-16 vs 2025-04-04View on EDGAR →
FINANCIAL ANALYSIS

DOMO demonstrated meaningful progress toward profitability with operating losses improving substantially from $59.3M to $39.1M, while net losses also narrowed considerably. The company reduced R&D expenses by 12.2% to $77.2M, indicating disciplined cost management, while accounts receivable grew 19.4% suggesting stronger billing activity. Overall, the financial picture reflects a company making deliberate moves toward profitability while maintaining growth investments.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+34%
-$59.3M→-$39.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+27.6%
-$81.9M→-$59.3M

Net income grew 27.6% — bottom-line growth signals improving overall business health.

Accounts Receivable
Balance Sheet
+19.4%
$71.5M→$85.5M

Receivables grew 19.4% — monitor days sales outstanding for collection efficiency.

R&D Expense
P&L
-12.2%
$87.9M→$77.2M

R&D spending cut 12.2% — could signal cost discipline or concerning reduction in innovation investment.

LANGUAGE CHANGES
NEW — 2026-04-16
PRIOR — 2025-04-04
ADDED
As of April 14, 2026, there were approximately 3,263,659 shares of the registrant's Class A common stock and 41,882,739 shares of the registrant's Class B common stock outstanding.
Our cloud-based AI and data products platform enables processes that are critically dependent on business data, which historically could take weeks or months, to be done on-the-fly, in as fast as minutes or seconds, at scale.
From marketing to operations, HR to finance, IT to product development, supply chain to sales, Domo s platform is designed to change the way organizations are managed and empower our customers to build data products, including through leveraging AI technologies, that generate measurable value for the business.
Artificial intelligence and machine learning capabilities can be applied to customer data to generate insights, trigger alerts, and support recommended actions based on predefined business rules and user configurations.
These capabilities are designed to operate within customer-defined governance controls and permissions, enabling users to review, approve, and execute actions, including writing data back to systems of record where authorized.
+7 more — sign up free →
REMOVED
As of April 2, 2025, there were approximately 3,263,659 shares of the registrant's Class A common stock and 36,675,927 shares of the registrant's Class B common stock outstanding.
Our cloud-based platform is a modern AI and data products platform that enables processes that are critically dependent on business intelligence data which historically could take weeks, months or longer to be done on-the-fly, in as fast as minutes or seconds, at scale.
From marketing to operations, HR to finance, IT to product development, supply chain to sales, Domo's platform is designed to change the way organizations are managed and empower our customers to deploy AI and build data products that generate measurable value for the business.
Artificial intelligence algorithms and machine learning can be applied to the data that allow alerts to be triggered and actions invited.
Users can receive these notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →